NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology

Clinical trial NCT04170985 · COMPLETED

Trial details

NCT number: NCT04170985
Sponsor: Illumina, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Neurologic Deficits Neurologic Disorder Neurologic Abnormalities

Start date: 2019-11-18
Primary completion: 2024-01-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.